Emergence Delirium、fBFI-ENO Score (Extraversion + Neuroticism - Openness) Based on the Fast Big Five Personality Scale-10、An Adult Patient With ASAI-III Who is Scheduled for Elective Non-cardiac Surgery and is to Undergo General Anesthesia With Tracheal Intubation

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHongjiao Xu

About this trial

The aim of this study is to verify the generalizability of the fBFI-ENO score (extraversion + neuroticism - openness) constructed based on the Rapid Big Five Personality Scale - 10 across different genders, ages, and surgical types,which has shown good predictive ability for Emergence Delirium in previous studies.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

General anesthesia with tracheal intubation is planned for elective non-cardiac surgery.

Age ≥18 years old, gender not limited;

American Society of Anesthesiologists (ASA) classification I-III;

Voluntarily participate in this project and sign the informed consent form.

Disqualifiers

The anesthesia method was temporarily changed to local anesthesia, regional anesthesia or intravenous anesthesia;

There was a clear cognitive dysfunction before the surgery (MMSE score lower than the qualified standard corresponding to the educational level: illiterates ≤ 17 points; primary school level ≤ 20 points; secondary (technical secondary) school level: ≤ 22 points; university (college) and above level: ≤ 23 points) or communication difficulties;

There is a history of mental illness or long-term use of psychotropic drugs;

It is expected to be transferred to the intensive care unit (ICU) immediately after the surgery or requires a sedated state and cannot undergo standard assessment in the PACU;

Trial population

Patients scheduled for non-cardiac surgery, undergoing general anesthesia with endotracheal intubation, aged 18 years or older, and with ASA classification of I-III.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

880 Participants
are grouped into 1 trial group
Group A: fBFI - ENO score

Trial outcomes

Primary outcomes

1

The occurrence of emergence delirium during the recovery period of general anesthesia

Sedation-agitation scale,A score of 5 to 7 is judged as delirium

Time frame
Within 1 hour after the operation

Secondary outcomes

1

delirium stratification

Light:It occurs under strong stimulation, such as suctioning phlegm, but stops as soon as the stimulation disappears. Moderate:It occurs without stimulation and lasts for at least 5 minutes, but does not require medical staff intervention by the staff. Heavy:It should last for at least 5 minutes and must be controlled through medication and/or physical restraints.

Time frame
within 1 hour after operation
2

Postoperative NRS pain and medication

NRS (Numerical Rating Scale, Digital Evaluation Scale) is composed of 11 numbers from 0 to 10. Patients use these 11 numbers from 0 to 10 to describe the intensity of pain. The higher the number, the more severe the pain.If NRS≥4,Sufentanil 5μg will be given.

Time frame
within 1 hour after operation

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hongjiao Xu

Lead sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Sponsor institution

Shanghai Pudong Hospital

Collaborator

Huashan Hospital

Collaborator

Jiangsu Taizhou People's Hospital

Collaborator

Shanghai Pulmonary Hospital, Shanghai, China

Collaborator

Jiangqiao Hospital,Jiading District,Shanghai

Collaborator

This trial is not recruiting at the moment. You can still explore other options: